Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 29 Lymphoma 17 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Vulvar Neoplasms 3 Testicular Neoplasms 3 Neoplasms, Germ Cell and Embryonal 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Immunoblastic 3 Seminoma 2 Ovarian Neoplasms 2 Neoplasms 2 Dendritic Cell Sarcoma, Interdigitating 2 Breast Neoplasms 2 Warts 1 Ulcer 1 Testicular Germ Cell Tumor 1 Teratoma 1 Stomach Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Processes 1 Ovarian Germ Cell Cancer 1 Neoplastic Processes 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1

Interventions

Nivolumab 13 Ipilimumab 10 pembrolizumab 8 cemiplimab 6 Surveys and Questionnaires 6 Biopsy 6 aldesleukin 5 Radiotherapy 5 Interleukin-2 5 Blood Specimen Collection 5 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Mohs Surgery 4 HhAntag691 4 Fluorouracil 4 Educational Status 4 Cyclophosphamide 4 sonidegib 3 fludarabine phosphate 3 fludarabine 3 avelumab 3 Vemurafenib 3 Surgical Procedures, Operative 3 Radiation 3 Petrolatum 3 Cetuximab 3 Aminolevulinic Acid 3 trametinib 2 dabrafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Neoplasms × Bleomycin × Clear all

NCT06647342 2025-01-23

BLESS

Zealand University Hospital

Phase 4 Recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡